Stefan Laufer
Chairman
Microbiology
Biotech Umea
Sweden
Biography
Stefan Laufer, is Professor for Pharmaceutical and Medicinal Chemistry at Tuebingen University. He received his degrees from Regensburg University. After 10 years in Pharmaceutical Industry (Head Drug Research, R&D Director Merckle GmbH) he joined in 1999 Tuebingen University as Chairman Pharm./Med. Chemistry. His research interests are anti-inflammatory drug discovery with various eicosanoid (COX-1,2,3, LOXs, mPGES1, cPLA2) and protein kinase targets (p38, JAKs, JNKs, CK1d, mtEGRFs). Three compounds from his lab entered clinical development phases. Dr. Laufer chairs the ICEPHA (Interfaculty Center for Pharmacogenomics and Drug Research), an academic drug discovery platform at Tuebingen University and Robert Bosch Hospital Stuttgart. He authored more than 360 publications, 14 books/bookchapters and is inventor in 42 patent families.
Research Interest
Microbiology